Inhibition of Microsomal Prostaglandin E2 Synthase Reduces Collagen Deposition in Melanoma Tumors and May Improve Immunotherapy Efficacy by Reducing T-cell Exhaustion.
Document Type
Article
Publication Date
7-1-2023
Publication Title
Cancer Res Commun
Keywords
Animals; Mice; Prostaglandin-E Synthases; Intramolecular Oxidoreductases; Cyclooxygenase 2; Dinoprostone; CD8-Positive T-Lymphocytes; T-Cell Exhaustion; Melanoma; Cyclooxygenase 1; Collagen; Immunotherapy; Tumor Microenvironment; california; genomics; sjci
Abstract
The arachidonic acid pathway participates in immunosuppression in various types of cancer. Our previous observation detailed that microsomal prostaglandin E2 synthase 1 (mPGES-1), an enzyme downstream of cyclooxygenase 2 (COX-2), limited antitumor immunity in melanoma; in addition, genetic depletion of mPGES-1 specifically enhanced immune checkpoint blockade therapy. The current study set out to distinguish the roles of mPGES-1 from those of COX-2 in tumor immunity and determine the potential of mPGES-1 inhibitors for reinforcing immunotherapy in melanoma. Genetic deletion of mPGES-1 showed different profiles of prostaglandin metabolites from that of COX-2 deletion. In our syngeneic mouse model, mPGES-1-deficient cells exhibited similar tumorigenicity to that of COX-2-deficient cells, despite a lower ability to suppress PGE2 synthesis by mPGES-1 depletion, indicating the presence of factors other than PGE2 that are likely to regulate tumor immunity. RNA-sequencing analysis revealed that mPGES-1 depletion reduced the expressions of collagen-related genes, which have been found to be associated with immunosuppressive signatures. In our mouse model, collagen was reduced in mPGES-1-deficient tumors, and phenotypic analysis of tumor-infiltrating lymphocytes indicated that mPGES-1-deficient tumors had fewer TIM3
SIGNIFICANCE: Collagen is a predominant component of the extracellular matrix that may influence the tumor immune microenvironment for cancer progression. We present here that mPGES-1 has specific roles in regulating tumor immunity, associated with several collagen-related genes and propose that pharmacologic inhibition of mPGES-1 may hold therapeutic promise for improving immune checkpoint-based therapies.
Clinical Institute
Cancer
Department
Oncology
Recommended Citation
Fukuda, Yasunari; Kim, Sun-Hee; Bustos, Matias A; Cho, Sung-Nam; Roszik, Jason; Burks, Jared K; Kim, Hong; Hoon, Dave S B; Grimm, Elizabeth A; and Ekmekcioglu, Suhendan, "Inhibition of Microsomal Prostaglandin E2 Synthase Reduces Collagen Deposition in Melanoma Tumors and May Improve Immunotherapy Efficacy by Reducing T-cell Exhaustion." (2023). Articles, Abstracts, and Reports. 7830.
https://digitalcommons.providence.org/publications/7830
